- Home
- ANEB vs ORIS Comparison
ANEB vs ORIS Comparison
Compare ANEB & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- ORIS
- Stock Information
- Founded
- ANEB 2020
- ORIS 2014
- Country
- ANEB United States
- ORIS China
- Employees
- ANEB N/A
- ORIS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- ANEB Health Care
- ORIS Consumer Staples
- Exchange
- ANEB Nasdaq
- ORIS Nasdaq
- Market Cap
- ANEB 111.8M
- ORIS 5.3M
- IPO Year
- ANEB 2021
- ORIS 2024
- Fundamental
- Price
- ANEB $2.71
- ORIS $0.15
- Analyst Decision
- ANEB Buy
- ORIS
- Analyst Count
- ANEB 2
- ORIS 0
- Target Price
- ANEB $8.00
- ORIS N/A
- AVG Volume (30 Days)
- ANEB 22.3K
- ORIS 4.6M
- Earning Date
- ANEB 11-14-2025
- ORIS 01-01-0001
- Dividend Yield
- ANEB N/A
- ORIS N/A
- EPS Growth
- ANEB N/A
- ORIS N/A
- EPS
- ANEB N/A
- ORIS 0.17
- Revenue
- ANEB N/A
- ORIS $15,014,000.00
- Revenue This Year
- ANEB N/A
- ORIS N/A
- Revenue Next Year
- ANEB N/A
- ORIS N/A
- P/E Ratio
- ANEB N/A
- ORIS $0.82
- Revenue Growth
- ANEB N/A
- ORIS N/A
- 52 Week Low
- ANEB $0.80
- ORIS $0.08
- 52 Week High
- ANEB $3.42
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- ANEB 60.42
- ORIS 47.23
- Support Level
- ANEB $2.50
- ORIS $0.14
- Resistance Level
- ANEB $2.76
- ORIS $0.15
- Average True Range (ATR)
- ANEB 0.13
- ORIS 0.01
- MACD
- ANEB 0.02
- ORIS -0.00
- Stochastic Oscillator
- ANEB 76.27
- ORIS 34.15
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).